BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2.200
+0.100 (4.76%)
May 29, 2025, 5:24 PM IDT

BioLineRx Revenue

BioLineRx had revenue of $255.00K USD in the quarter ending March 31, 2025, a decrease of -96.28%. This brings the company's revenue in the last twelve months to $22.34M, up 91.68% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.

Revenue (ttm)
$22.34M
Revenue Growth
+91.68%
P/S Ratio
0.59
Revenue / Employee
$797.86K
Employees
28
Market Cap
49.12M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.94M24.14M502.92%
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 61.87B
Danel (Adir Yeoshua) 2.81B
Kamada 622.70M
Bait Bakfar 103.40M
SofWave Medical 235.09M
Novolog (Pharm-Up 1966) 2.02B
BrainsWay 161.81M
Ilex Medical 920.37M
Revenue Rankings